West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend

West Pharma (WST) Misses Q3 EPS by 10c; Offers FY22 Revenue Guidance

October 27, 2022 6:15 AM EDT

West Pharma (NYSE: WST) reported Q3 EPS of $2.03, $0.10 worse than the analyst estimate of $2.13. Revenue for the quarter came in at $686.9 million versus the consensus estimate of $728.11 million.

GUIDANCE:

West Pharma sees FY2022 revenue of $2.83-2.84 billion, versus the consensus... More